These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23487226)
1. Using paliperidone as a monotherapeutic agent on a schizophrenic patient with cirrhosis of the liver. Chou HW; Chen CL J Neuropsychiatry Clin Neurosci; 2013; 25(1):E37. PubMed ID: 23487226 [No Abstract] [Full Text] [Related]
2. Successful use of paliperidone in a clozapine-resistant schizophrenic patient. Hsieh TH; Liu CT J Neuropsychiatry Clin Neurosci; 2013; 25(2):E36. PubMed ID: 23686056 [No Abstract] [Full Text] [Related]
3. Improvements in micturition and urinary retention after switching from amisulpiride to paliperidone in a schizophrenic patient. Lai CH J Neuropsychiatry Clin Neurosci; 2012; 24(4):E11-2. PubMed ID: 23224462 [No Abstract] [Full Text] [Related]
4. Paliperidone as an alternative for risperidone in a case of schizophrenia with retrograde ejaculation. Kandasamy A J Neuropsychiatry Clin Neurosci; 2012; 24(3):E17-8. PubMed ID: 23037663 [No Abstract] [Full Text] [Related]
5. Improvement of oral dyskinesia after switching from aripiprazole to paliperidone: a case report. Lai CH J Neuropsychiatry Clin Neurosci; 2011; 23(3):E18. PubMed ID: 21948908 [No Abstract] [Full Text] [Related]
6. Paliperidone: An improvement over risperidone? Dopheide JA Am J Health Syst Pharm; 2008 Mar; 65(5):401. PubMed ID: 18281730 [No Abstract] [Full Text] [Related]
7. Remission of drug-induced hepatitis after switching from risperidone to paliperidone. Paulzen M; Orfanos S; GrĂ¼nder G Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492 [No Abstract] [Full Text] [Related]
12. [Efficacy, tolerability and safety of paliperidone extended-release in the treatment of schizophrenia and schizoaffective disorder]. Bellantuono C; Santone G Riv Psichiatr; 2012; 47(1):5-20. PubMed ID: 22358213 [TBL] [Abstract][Full Text] [Related]
13. Paliperidone overdose in a patient with schizophrenia. Chang JP; Huang CC; Su KP Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):418. PubMed ID: 19995588 [No Abstract] [Full Text] [Related]
14. Randomized, double-blind, placebo-controlled study of paliperidone extended-release and quetiapine in inpatients with recently exacerbated schizophrenia. Canuso CM; Dirks B; Carothers J; Kosik-Gonzalez C; Bossie CA; Zhu Y; Damaraju CV; Kalali AH; Mahmoud R Am J Psychiatry; 2009 Jun; 166(6):691-701. PubMed ID: 19411369 [TBL] [Abstract][Full Text] [Related]
15. Practical guidelines on the use of paliperidone palmitate in schizophrenia. Newton R; Hustig H; Lakshmana R; Lee J; Motamarri B; Norrie P; Parker R; Schreiner A Curr Med Res Opin; 2012 Apr; 28(4):559-67. PubMed ID: 22321007 [TBL] [Abstract][Full Text] [Related]
16. Safety of paliperidone extended-release in patients with schizophrenia or schizoaffective disorder and hepatic disease. Amatniek J; Canuso CM; Deutsch SI; Henderson DC; Mao L; Mikesell C; Rodriguez S; Sheehan J; Alphs L Clin Schizophr Relat Psychoses; 2014 Apr; 8(1):8-20. PubMed ID: 23428785 [TBL] [Abstract][Full Text] [Related]
17. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. Angelucci F; Ricci V; Martinotti G; Caltagirone C; Bria P Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1277-8. PubMed ID: 19555731 [No Abstract] [Full Text] [Related]
18. [Paliperidone]. Oberpichler-Schwenk H Med Monatsschr Pharm; 2006 Aug; 29(8):280-2. PubMed ID: 16927595 [No Abstract] [Full Text] [Related]
20. Tolerability of paliperidone: a meta-analysis of randomized, controlled trials. Harrington CA; English C Int Clin Psychopharmacol; 2010 Nov; 25(6):334-41. PubMed ID: 20706126 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]